BUSINESSMay 26 · 08:20 UTCBLOOMBERGLaura Gardner Cuesta, Julia Fioretti

Hong Kong-Listed Biotech Insilico Is Said to Explore UAE Listing

Hong Kong-listed biotech company Insilico is reportedly exploring a potential listing in the United Arab Emirates, with Abu Dhabi mentioned as a possible location. The move could expand the company's financial reach and international presence.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

InsilicoorganizationHong KongplaceUnited Arab EmiratesplaceAbu Dhabiplacebiotechtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSMay 1 · 15:16 UTC
Leo Pharma Is Said to Add More Banks to Copenhagen IPO Lineup
BUSINESSMay 18 · 00:27 UTC
Elliott Builds Stake in Life-Science Firm Bio-Rad, WSJ Says
BUSINESSApr 27 · 16:04 UTC
Italy’s Angelini Said to Explore Catalyst Pharma Acquisition
BUSINESSApr 27 · 11:25 UTC
Novo-Backed Biotech Hemab Seeks to Raise $212 Million in US IPO
BUSINESSApr 16 · 05:46 UTC
Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon
BUSINESSMay 11 · 09:01 UTC
Reliance Is Said to Plan Offering All New Shares in Jio IPO